Denali Therapeutics Inc (DNLI)
24.22
-0.20
(-0.82%)
USD |
NASDAQ |
Nov 21, 16:00
24.26
+0.04
(+0.14%)
After-Hours: 20:00
Denali Therapeutics Total Assets (Quarterly): 1.454B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.454B |
| June 30, 2024 | 1.503B |
| March 31, 2024 | 1.581B |
| December 31, 2023 | 1.154B |
| September 30, 2023 | 1.237B |
| June 30, 2023 | 1.306B |
| March 31, 2023 | 1.409B |
| December 31, 2022 | 1.460B |
| September 30, 2022 | 1.228B |
| June 30, 2022 | 1.292B |
| March 31, 2022 | 1.321B |
| December 31, 2021 | 1.404B |
| September 30, 2021 | 1.450B |
| June 30, 2021 | 1.510B |
| March 31, 2021 | 1.548B |
| Date | Value |
|---|---|
| December 31, 2020 | 1.604B |
| September 30, 2020 | 1.070B |
| June 30, 2020 | 647.34M |
| March 31, 2020 | 695.86M |
| December 31, 2019 | 553.23M |
| September 30, 2019 | 602.98M |
| June 30, 2019 | 637.60M |
| March 31, 2019 | 676.60M |
| December 31, 2018 | 661.98M |
| September 30, 2018 | 544.48M |
| June 30, 2018 | 572.06M |
| March 31, 2018 | 613.95M |
| December 31, 2017 | 486.72M |
| September 30, 2017 | 210.31M |
| December 31, 2016 | 271.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
553.23M
Minimum
Dec 2019
1.604B
Maximum
Dec 2020
1.271B
Average
1.363B
Median
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 13.59M |
| Perspective Therapeutics Inc | 391.15M |
| Protalix BioTherapeutics Inc | 61.56M |
| Electromed Inc | 48.92M |
| Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 135.52M |
| Shareholders Equity (Quarterly) | 1.318B |